[company_age]3.0[/company_age][employees]2-10 employees[/employees][description]Hemera Pharma, a spin-off company from the University of Verona and the University of Milan, specializes in regenerative medicine for neurological diseases. Founded by scientists with extensive research experience in the field, Hemera's mission is to develop a revolutionary cellular therapy for the regeneration of damaged nerve tissues, initially focusing on the treatment of acute spinal cord injuries. Their unique approach utilizes autologous immune cells, trained in vitro to optimize their reparative capabilities within the challenging environment of the spinal cord. This sets them apart from other companies in the field that may use different cell types or approaches.[/description][ps]REMaST® Cellular Therapy for Spinal Cord Injuries[/ps]